As2O3 may be a treatment option for adenoid cystic carcinoma of salivary gland

Medical Hypotheses

Volumn 75, Issue 6, 2010, Pages 490-491

  Fu, Zhao Chen ^a   Zhang, Bin ^a   Fu, Zhao Jun ^b  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b AIR FORCE GENERAL HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ARSENIC TRIOXIDE; GROWTH INHIBITOR; ORGANOARSENIC DERIVATIVE; OXIDE;

ADENOID CYSTIC CARCINOMA; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER CHEMOTHERAPY; CANCER SUSCEPTIBILITY; CELL TRANSFORMATION; CHROMOSOME SEGREGATION; HUMAN; SALIVARY GLAND; DRUG EFFECT; SALIVARY GLAND TUMOR;

APOPTOSIS; ARSENICALS; CARCINOMA, ADENOID CYSTIC; GROWTH INHIBITORS; HUMANS; OXIDES; SALIVARY GLAND NEOPLASMS;

EID: 77958488937     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2010.07.001     Document Type: Article

References (9)

1. Conley J.J., Dingman D.L. Adenoid cystic carcinoma of the head and neck (cylindroma). Arch Otolaryngol 1974, 100:81-90.
2. Casler J.D., Conley J.J. Surgical management of adenoid cystic carcinoma of the parotid gland. Otolaryngol Head Neck Surg 1992, 106:332-338.
3. Ishibashi H., Shiratuchi T., Nakagawa K., et al. Hypoxia-induced angiogenesis of cultured human salivary gland carcinoma cells enhances vascular endothelial growth factor production and basic fibroblast growth factor release. Oral Oncol 2001, 37:77-83.
4. Spiro R.H. Distant metastasis in adenoid cystic carcinoma of salivary origin. Am J Surg 1997, 174(5):495-498.
5. Zhang P., Wang S.Y., Hu X.H. Arsenic trioxide treated 72 cases of acute promyelocytic leukemia. Chin J Hematol 1996, 17:58-72.
6. Shen Z.X., Chen G.Q., Ni J.H., et al. Use of arsenic trioxide in the treatment of acute promyelocytic leukemia (APL): clinical efficacy and pharmacokinetics in relapsed patients. Blood 1997, 89:3354-3360.
7. Niu C., Yan H., Yu T., et al. Studies on treatment of acute promyelocytic leukemia with arsenic trioxide: remission induction, follow-up, and molecular monitoring in 11 newly diagnosed and 47 relapsed acute promyelocytic leukemia patients. Blood 1999, 94:3315-3324.
8. Soignet S.L., Maslak P., Wang Z.G., et al. Complete remission after treatment of acute promyelocytic leukemia with arsenic trioxide. N Engl J Med 1998, 339:1341-1348.
9. Wu Yi-Chen, Yen Wen-Yen, Lee Te-Chang, et al. Heat shock protein inhibitors, 17-DMAG and KNK437, enhance arsenic trioxide-induced mitotic apoptosis. Toxicol Appl Pharm 2009, 236(2):231-238.